Scientific Programme 2019

Information on Scientific Programme of the ASM

SCIENTIFIC PROGRAMME

To download a copy of the registration programme for the 2019 Annual Scientific Meeting please click HERE

 

Contents

  1. Programme Outline
  2. Plenary Speakers and Topics
  3. Parallel Sessions A1-A4
  4. Parallel Sessions B1-B4
  5. Parallel Session C1-C4

Programme Outline

DAY 1: WEDNESDAY 1 MAY 2019
09:00-18:00 Registration Desk open
09:00-18:00 Technical Exhibition and E-poster Exhibition open
10:00-10:15 Welcome by the BPS President and Chair of the Scientific Programme Committee
10:15-10:55 Plenary Session 1 - Pat Wall
10:55-11:35 Plenary Session 2
11:35-12:05 Coffee Break, Technical and E-poster Exhibitions
12:05-12:45 Plenary Session 3
12:45-13:45 Lunch, Technical and E-poster Exhibitions
13:45-15:15 Parallel Sessions A1-A4
15:15-15:45 Coffee Break, Technical and E-poster Exhibitions
15:45-16:45 SIG Business Meetings
16:50-17:50 Industry Sponsored Symposium


DAY 2: THURSDAY 2 MAY 2019
07:30-18:00 Registration Desk open
07:30-18:00 Technical Exhibition and E-poster Exhibition open
08:00-09:00 Industry Sponsored Symposium
09:00-10:00 SIG Business Meetings
10:05-11:35 Parallel Sessions B1-B4
11:35-12:05 Coffee Break, Technical and E-poster Exhibitions
12:05-12:45 Plenary Session 4
12:45-13:45 Lunch, Technical and E-poster Exhibitions
13:45-14:25 Plenary Session 5
14:25-15:35 AGM for British Pain Society Members
14:25-15:35 Networking Session for Non-Members
15:35-16:05 Coffee Break, Technical and E-poster Exhibitions
16:05-16:45 Plenary Session 6
16:50-17:50 Industry Sponsored Symposium
18:00 Drinks reception


DAY 3: FRIDAY 3 MAY 2019
08:30-15:30 Registration Desk open
08:30-15:30 Technical Exhibition and E-poster Exhibition open
09:00-10:00 SIG Business Meetings
10:05-11:35 Parallel Sessions C1- C4
11:35-12:05 Coffee Break, Technical and E-poster Exhibitions
12:05-13:15 Plenary Session 7 – Oral poster presentations
13:15-14:15 Lunch, Technical and E-poster Exhibitions
14:15-14:55 Plenary Session 8
14:55-15:35 Plenary Session 9 – British Pain Society Lecture
15:35-15:45 Awards and Close

Back to top

Plenary Speakers and Topics

Pat Wall Lecture - Plenary Session 1

Professor Bridget Lumb
Descending Pain Modulatory Systems: Mechanisms, Significance and Translation

Descending control of spinal nociception that originates within the brain and acts to modulate spinal transmission of nociceptive transmission is a major determinant of the acute and chronic pain experience. Investigations of these systems in basic scientific research is critical to developing therapeutic strategies for the relief of pain. Despite our best efforts, something is lost in translation and we need to question if we are employing the right approaches. It is these important issues that will be explored in this presentation.


Plenary Session 2

Professor Paul Eldridge
Neuromodulation; a review of the evidence and its clinical applications

“Neuromodulation” is best known for pain yet encompasses many other pathologies. Evidence for chronic neuropathic pain by spinal cord stimulation is established, but predates a number of technical advances – high frequency,
burst, whisper, high density. There is more peripheral nerve stimulation – the DRG, the occipital nerve and sphenopalatine ganglion. Other areas for pain are deep brain stimulation, and transcranial magnetic stimulation. Other
conditions with neuromodulatory solutions are epilepsy – deep brain and vagal nerve, and the latter may have other effects – use for rheumatoid arthritis, and depression. DBS is well evidenced for movement disorders but there is much further potential.

 


Plenary Session 3

Professor Richard Langford
What's new in acute pain?

Although acute pain management remains a challenge, multimodal therapy with various non-opioid adjuvants, local anaesthetic techniques and avoidance of parenteral routes have improved the patients’ pain experience. Enhanced recovery programmes after surgery are driving innovative strategies to eliminate ‘analgesia gaps’ (breakthrough pain), promote early mobilisation and to improve pain management plans and review after discharge from hospital.
 


Plenary Session 4

Dr Stephen Alexander
Barriers to the user of Cannabis and cannabinoids to treat pain

Cannabis sativa is one of the oldest cultivated plants with reported medicinal use in India and Egypt over 4000 years ago. In the modern era, Cannabis has been used for multiple indications, including pain, although the ‘real’ evidence for benefit is limited. The gap between anecdotal and scientific evidence derives from variables at multiple levels, including plant metabolite levels and doses; administration route; pharmacokinetics and patient profile. Recent changes in legislation, in the UK and elsewhere, regulating the availability of Cannabis derived medicinal products should prompt more systematic assessments of benefit (and potential harms) of these agents.
 


Plenary Session 5

Professor Nanna Finnerup
Neuropathic pain following cancer treatment

Neuropathic pain can be a long-lasting and debilitating complication to cancer treatments and is known to affect the quality of life in patients with cancer and in disease-free cancer survivors. Neuropathic pain is common
following surgeries with high risk of major nerve damage such as mastectomy, lymph node excision, and thoracotomy. Polyneuropathy is a common chronic complication to treatment with several types of chemotherapy. It is usually a length-dependent sensory polyneuropathy where symptoms have a “glove-andstocking” distribution and can be painful. Risk factors, diagnostic criteria and treatment of neuropathic pain following cancer treatment will be discussed.

 



Plenary Session 6

Professor Steven Linton
The role of social context in pain: why communication is central

Context matters. Indeed, it is a central, but missing link, in the biopsychosocial model where social aspects are often poorly understood. In this talk I will begin by defining social context and the idea of context sensitivity. Subsequently, I will review what we know about the impact of social context on pain perception. Finally, we will examine how social context might be harnessed to improve treatment in clinical situations. Since communication is a central factor in the social environment, I conclude with a simple method for improving communication which all practitioners may employ and benefit from.
 


Plenary Session 7

Oral presentations from the top six poster submissions


Plenary Session 8

Dr Benjamin Ellis
Analogue symptoms. Digital health

Clinical services are stretched as never before. The number of people living with disabling chronic pain is rising, but with no prospect of increased resources for health services. Whether it’s trying to do more with less, support people to improve their own health, or spot patterns in big data, some think that the answers are digital. So can technology save us, or is this all a mirage? This session will review current NHS digital health policy and practice, consider the current evidence and explore possible future trends.
 


BPS Lecture - Plenary Session 9

Professor David Bennett
How can we better stratify patients with neuropathic pain and what are the implications for treatment?

Neuropathic pain arises as a consequence of a lesion or disease of the sensory nervous system. It is increasingly common and difficult to treat. The last decade has seen significant advances in the methods we can use to stratify patients with neuropathic pain. We can generate classifications which are not just dependent on the aetiology of the injury but include sensory profile, physiological outcomes and genetics. Such stratification is improving diagnosis and ultimately will aid treatment selection for precision medicine.

 

Back to top

Parallel Sessions A1-A4

Participants are asked to choose one from the following four sessions below and indicate their preferred option on the online registration form.

A1: Compassion Focused Therapy for Pain: How to use self-compassion to soothe pain-related distresss, self-criticism and allow pacing of activity
Co-chaired by Dr Zoey Maplus and Dr Lesley Armitage  

  • Compassion Focused Therapy: Theoretical background and clinical application to working with persistent pain. Dr Zoey Malpus
  • Qualitative patient reflections on using this approach. Practical Demonstration – Compassionate Flow Exercise. Dr Lesley Armitage
  • Quantitiative outcomes of a CFT – Pain collaboration between Manchester and Durham Pain Teams. Further practical demonstrations of CFT techniques. Dr Zoey Malpus and Dr Lesley Armitage


A2: Benzodiazepines: risks, interactions, and impact on pain management treatment
Chaired by Dr Peter Brook

  • Benzodiazepines: mortality, interactions and overdose. Dr Peter Brook
  • Benzodiazepines: impact on psychological and physical treatment. Dr Jeremy Gauntlett-Gilbert
  • Benzodiazepines: anxiety treatment, addiction, and dependence. Dr Parashar Ramanuj


A3: Patients as Research Partners
Chaired by Mrs Margaret Whitehead

  • Why involve patients in research? Evidence base of working with patients in the design and development of research projects. Professor Kate Seers
  • How to do it. Professional experience of working with patients as research partners. Ms Sharon Grieve
  • What worked for me. Patient experience of working with professionals. Patient Representative.

 

A4: The first cut is the deepest
Chaired by Ms Felicia Cox

  • What’s new in neuropathic pain. Dr Bernhard Frank
  • Opioid prescribing and de-prescribing in acute pain. Dr Dev Srivastava
  • Acute pain – Where will we be in 10 years. Professor Richard Langford

     

Back to top

Parallel Sessions B1-B4

Participants are asked to choose one from the following four sessions below and indicate their preferred option on the online registration form.

B1: Essential Pain Management (EPM) - a simple structure to teach a complex subject
Chaired by Dr Helen Makins

  • The EPM approach – what it is and how it works. Dr Helen Makins
  • EPM in practice – interactive session. Ms Sharon Kitcatt
  • Learning from experience and tips for running EPM. Dr Mike O’Connor

 

B2: Biologics for pain
Chaired by Professor David Walsh

  • Antibodies to nerve growth factor; rocking the boat for osteoarthritis and low back pain. Professor David Walsh
  • Antibodies to calcitonin-gene related peptide; removing the threat of pain attacks. Dr Susan Brain 
  • Providing a biologics service for inflammatory arthritis; who needs secondary care? Dr Ben Parker
     

B3: Squaring a circle: new models for pain services
Chaired by Professor Roger Knaggs

  • The changing landscape of NHS commissioning: ICS and what this means for people with pain. Mrs Ellen Rule
  • Thinking about pain in a different way: supporting people with pain to live well. Dr Cathy Stannard
  • Evolution of a community pain service: an unexpected story. Dr Greg Hobbs
     

B4: Interdisciplinary Neuromodulation Clinic 
Chaired by Dr Ashish Shetty

  • Neurosurgeon in Neuromodulation Clinic. Prof Robert Brownstone
  • Urogynaecologist in Pain Clinic. Miss Sohier Elneil
  • Expanding Indications for Neuromodulation. Dr Ashish Shetty
  • MDT Assessment of Neuromodulation Patients. Ms Sarah Corker 
     

 

Back to top

Parallel Session C1-C4

Participants are asked to choose one from the following four sessions below and indicate their preferred option on the online registration form.

C1: How can surgical practitioners deliver effective reassurance to people with back pain who are not offered surgery?
Chaired by Professor Tamar Pincus

  • Reassurance, validation and patient outcomes- the story so far. Professor Tamar Pincus 
  • What do patients want from surgical consultations that result in discharge without treatment? Ms Kathrin Braeuninger-Weimer
  • What can surgeons realistically do to improve patients’ satisfaction?Mr Naffis Anjarwalla
     

C2: Growing up with chronic pain: Trials and tribulations in adolescence.
Co-chaired by Dr Line Caes and Dr Abbie Jordan

  • Telling my story, telling their story: Exploring future perceptions in young people who experience chronic pain. Dr Abbie Jordan
  • Which passengers are on your bus? A qualitative analysis of the hurdles adolescents with chronic pain need to overcome to make progress. Dr Line Caes
  • Treating adolescents with chronic pain: trials and tribulations for clinicians. Dr Jeremy Gauntlett-Gilbert
     

C3: Addressing the evidence to practice gap in pain management
Chaired by Ms Gail Sowden

  • Optimising the translation of evidence into practice. Ms Gail Sowden
  • What can we learn from Implementation Science? Ms Laura Swaithes 
  • What is the role of educational theory and pedagogy in enabling the delivery of effective pain education and teaching in practice and in educational settings? Mrs Sue Jenkins
     

C4: Maximise the effect of your interventions - selection and technique
Co-Chaired by Dr Sumit Gulati & Dr Neil Collighan

  • Expert Panel: Cervical radicular pain: Transforaminal, Interlaminar, Catherter approaches and when not to inject. Dr Ron Cooper and Dr David Pang
  • Case studies in the Dorsal Ramus and its connections - How do they complicate facet joint pai. Dr Sherdil Nath
  • Failed back and failed neck surgery: selecting patients and navigating pathways for Spinal Cord Stimulation. Dr Simon Thomson


     

 

Back to top